Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06265870
NA

Specific Versus Empirical Anthelminthic Treatment in Eosinophilia

Sponsor: Prince of Songkla University

View on ClinicalTrials.gov

Summary

There are a few guidelines recommend about management of eosinophilia worldwide, most of guielines recommend a thorough history-taking and physical examination. Subsequently, investigations are requested based on suspected causes. In cases where parasite infection is suspected, particularly in developing countries, stool microscopy and serology are recommended. However, limitations such as low sensitivity of stool microscopy, the inconvenience of collecting multiple stool samples, and the high cost and unavailability of serology may arise. Consequently, some physicians opt for empiric anthelminthic regimens in managing eosinophilic patients, even without stool tests or if stool test results are normal. If subsequent complete blood count (CBC) results show a recovery of absolute eosinophil count, it is assumed that eosinophilia was caused by a parasite infection. While some studies demonstrate the efficacy and simplicity of this approach, there is a risk of overestimating parasite infection in eosinophilic patients, potential adverse drug reactions from unnecessary anthelminthic treatment, and the possibility of drug resistance due to inappropriate dosing. To address this gap, no study has yet compared the efficacy between specific anthelminthic treatment based on test results and empirical anthelminthic treatment in eosinophilic patients. Therefore, the investigators are conducting this study.

Official title: Comparison of Outcome Between Specific Anthelminthic Treatment According to Test Results and Empirical Anthelminthic Treatment in Eosinophilic Patient

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

700

Start Date

2024-05-01

Completion Date

2025-12-31

Last Updated

2024-09-24

Healthy Volunteers

No

Conditions

Interventions

DRUG

Albendazole

Participants receive empiric anthelminthic treatment which is albendazole 400 mg twice a day for seven consecutive days

DRUG

Ivermectin or albendazole

Participants will receive specific anthelminthic treatment tailored to the results of the stool tests

Locations (1)

Prince of Songkla University - Hat Yai Campus: Prince of Songkla University

Hat Yai, Changwat Songkhla, Thailand